The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for children with Attention Deficit Hyperactivity Disorder (ADHD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
121
Site Reference ID/Investigator# 7536
Little Rock, Arkansas, United States
Site Reference ID/Investigator# 7954
Bradenton, Florida, United States
Site Reference ID/Investigator# 7543
ADHD-RS-IV (HV)
Time frame: Screening, Day -1, Day 7, Day 14, Day 28, Day 42
CSHQ
Time frame: Day-1, Day 28, Day 42
CGI-P
Time frame: Day -1, Day 21, Day 42
BRIEF
Time frame: Day -1, Day 28, Day 42
CGI-ADHD-S
Time frame: Screening, Day -1, Day 7, Day 14, Day 28 and Day 42
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Jacksonville, Florida, United States
Site Reference ID/Investigator# 7542
Orlando, Florida, United States
Site Reference ID/Investigator# 7537
Libertyville, Illinois, United States
Site Reference ID/Investigator# 7561
Overland Park, Kansas, United States
Site Reference ID/Investigator# 7560
Troy, Michigan, United States
Site Reference ID/Investigator# 7559
Omaha, Nebraska, United States
Site Reference ID/Investigator# 7541
Las Vegas, Nevada, United States
Site Reference ID/Investigator# 7564
Oklahoma City, Oklahoma, United States
...and 3 more locations